Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant

被引:50
作者
Binyamin, Orli [1 ]
Larush, Liraz [2 ]
Frid, Kati [1 ]
Keller, Guy [1 ]
Friedman-Levi, Yael [1 ]
Ovadia, Haim [1 ]
Abramsky, Oded [1 ]
Magdassi, Shlomo [2 ]
Gabizon, Ruth [1 ]
机构
[1] Hadassah Univ Hosp, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Casali Inst Chem, Jerusalem, Israel
关键词
nanodrops; PSO; EAE; oxidative stress; neurodegeneration; SOLID LIPID NANOPARTICLES; POMEGRANATE SEED OIL; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; MOLECULAR-MECHANISMS; LINOLEIC-ACID; BRAIN; PEROXIDATION; MICE; LIPOPROTEINS;
D O I
10.2147/IJN.S92704
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and is associated with demyelination, neurodegeneration, and sensitivity to oxidative stress. In this work, we administered a nanodroplet formulation of pomegranate seed oil (PSO), denominated Nano-PSO, to mice induced for experimental autoimmune encephalomyelitis (EAE), an established model of MS. PSO comprises high levels of punicic acid, a unique polyunsaturated fatty acid considered as one of the strongest natural antioxidants. We show here that while EAE-induced mice treated with natural PSO presented some reduction in disease burden, this beneficial effect increased significantly when EAE mice were treated with Nano-PSO of specific size nanodroplets at much lower concentrations of the oil. Pathological examinations revealed that Nano-PSO administration dramatically reduced demyelination and oxidation of lipids in the brains of the affected animals, which are hallmarks of this severe neurological disease. We propose that novel formulations of natural antioxidants such as Nano-PSO may be considered for the treatment of patients suffering from demyelinating diseases. On the mechanistic side, our results demonstrate that lipid oxidation may be a seminal feature in both demyelination and neurodegeneration.
引用
收藏
页码:7165 / 7174
页数:10
相关论文
共 52 条
[1]  
Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]
[2]   Protein aggregation diseases: pathogenicity and therapeutic perspectives [J].
Aguzzi, Adriano ;
O'Connor, Tracy .
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (03) :237-248
[3]   LINOLEIC-ACID PASSAGE THROUGH THE BLOOD-BRAIN-BARRIER AND A POSSIBLE EFFECT OF AGE [J].
AVELLINI, L ;
TERRACINA, L ;
GAITI, A .
NEUROCHEMICAL RESEARCH, 1994, 19 (02) :129-133
[4]   The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: Effect of copolymer 1 on MOG-induced disease [J].
BenNun, A ;
Mendel, I ;
Bakimer, R ;
FridkisHareli, M ;
Teitelbaum, D ;
Arnon, R ;
Sela, M ;
deRosbo, NK .
JOURNAL OF NEUROLOGY, 1996, 243 (04) :S14-S22
[5]   Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity [J].
Blasi, Paolo ;
Schoubben, Aurelie ;
Traina, Giovanna ;
Manfroni, Giuseppe ;
Barberini, Lanfranco ;
Alberti, Paolo Francesco ;
Cirotto, Carlo ;
Ricci, Maurizio .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 454 (01) :316-323
[6]   Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis [J].
Brown, David A. ;
Sawchenko, Paul E. .
JOURNAL OF COMPARATIVE NEUROLOGY, 2007, 502 (02) :236-260
[7]   Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins [J].
Butterfield, DA ;
Kanski, J .
MECHANISMS OF AGEING AND DEVELOPMENT, 2001, 122 (09) :945-962
[8]   Oxidation of Helix-3 Methionines Precedes the Formation of PK Resistant PrPSc [J].
Canello, Tamar ;
Frid, Kati ;
Gabizon, Ronen ;
Lisa, Silvia ;
Friedler, Assaf ;
Moskovitz, Jackob ;
Gasset, Maria ;
Gabizon, Ruth .
PLOS PATHOGENS, 2010, 6 (07) :1-10
[9]   OXIDATIVE STRESS AND REDUCED GLUTAMINE SYNTHETASE ACTIVITY IN THE ABSENCE OF INFLAMMATION IN THE CORTEX OF MICE WITH EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
Castegna, A. ;
Palmieri, L. ;
Spera, I. ;
Porcelli, V. ;
Palmieri, F. ;
Fabis-Pedrini, M. J. ;
Kean, R. B. ;
Barkhouse, D. A. ;
Curtis, M. T. ;
Hooper, D. C. .
NEUROSCIENCE, 2011, 185 :97-105
[10]   Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration [J].
Chen, Sam ;
Tam, Yuen Yi C. ;
Lin, Paulo J. C. ;
Leung, Alex K. K. ;
Tam, Ying K. ;
Cullis, Pieter R. .
JOURNAL OF CONTROLLED RELEASE, 2014, 196 :106-112